This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slid 7.83% to $23.08 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.12% to 11,196.22 and Dow Jones Industrial Average falling 0.63% to 33,536.70. The stock's fall snapped a two-day winning streak. Novavax Inc. closed $213.42 below its 52-week high ($236.50), which the company achieved on December 20th.
The stock underperformed when compared to some of its competitors Monday, as Replimune Group Inc. (REPL) fell 1.71% to $20.64, VBI Vaccines Inc. (VBIV) rose 3.80% to $0.62, and AnaptysBio Inc. (ANAB) fell 2.42% to $30.22. Trading volume (4.6 M) remained 576,527 below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2022.
(END) Dow Jones Newswires
November 14, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.